Risk for Imminent Delivery in Preeclampsia Based on the sFlt-1/PlGF Ratio: Do We Need New Cut-Offs?
Authors:
Open Access
- 6 February 2025
- journal article
- gebfra science
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (02) , 190-199
Abstract
It is still difficult to predict the outcome of preeclampsia and determine the individual procedure with regards to the time of birth. Cut-offs of the sFlt-1/PlGF ratio with a high risk for imminent delivery have been previously published and analyzed by our study group, but could not be confirmed. The aim of the current study is to re-evaluate the described cut-off values again in a new period of time.We performed a retrospective analysis (IRB 1279/2020) including all preeclampsia patients delivering in our department over a 3-year period. Patients were divided into 2 groups – gestational week 24+0–33+6 with an s-Flt1/PlGF > 655.2 and 34+0–37+0 weeks with an sFlt-1/PlGF > 201 and were compared with preeclampsia patients of the same weeks with sFlt-1/PlGF values below the described cut-offs. Correlation between sFlt-1/PlGF ratio and time to delivery was assessed.The association between sFlt-1/PlGF above the threshold and delivery within 48 h is significant for the high ratio early group (p < 0.01) but not for the high ratio late group (p = 0.62). In the early group, 60% of patients with sFlt-1/PlGF > 655.2 but only 8% in the low ratio group delivered within 48 h. In both the early and the late preeclampsia group, a high number of patients remained pregnant even though they showed elevated ratios.High sFlt-1/PlGF ratios seem to correlate with a shorter pregnancy duration to some extent. Nevertheless, not all patients need to be delivered within 48 h, so the decision should never be based on the laboratory test alone.Keywords
This publication has 39 references indexed in Scilit:
- Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trialAmerican Journal of Obstetrics and Gynecology, 2021
- Performance of soluble fms-like tyrosine kinase-1–to–placental growth factor ratio of ≥85 for ruling in preeclampsia within 4 weeksAmerican Journal of Obstetrics and Gynecology, 2021
- Retrospective evaluation of established cut-off values for the sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia patientsPregnancy Hypertension, 2020
- Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trialThe Lancet, 2019
- Global burden of prematuritySeminars in Fetal and Neonatal Medicine, 2016
- The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHPPregnancy Hypertension, 2014
- The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patientsAmerican Journal of Obstetrics and Gynecology, 2012
- Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Prediction of adverse outcomes by common definitions of hypertension in pregnancyObstetrics & Gynecology, 2001